This company is absolutely loaded up with COVID vaccine cash.

It has been using that money to buy up other companies to strengthen its pipeline moving forward.

However, the market isn’t paying attention to the long term.

It’s worried that in the short term, there will be fewer COVID vaccines sold and earnings could go down.

WHATEVER!

This pick is making great moves for growth and health over the long run, and that is exactly why it is still one of the picks I consider a core part of my portfolio.

Let’s get into it…